The family of proteins called matrix metalloproteinases (MMPs) are a c
lass of structurally related proteins that are collectively responsibl
e for the metabolism of extracellular matrix proteins. These zinc and
calcium dependent enzymes, which include the collagenases, stromelysin
s and gelatinases, are involved in normal tissue remodelling processes
such as wound healing, pregnancy and angiogenesis. Under physiologica
l conditions, in addition to the regulated proteolyses of inactive pre
cursors to the active form, the degradative nature of these enzymes ar
e precisely controlled by endogenous inhibitors (TIMPs). The excess sy
ntheses and production of these proteins lead to the accelerated matri
x degradation associated with diseases such as arthritis, cancer and m
ultiple sclerosis. The MMPs have therefore proved to be attractive tar
gets for structure based drug design. The pursuit of low molecular wei
ght inhibitors of these proteins have encouraged structural studies on
several members of family, so that the molecular details of enzyme-in
hibitor interactions of the MMPs have become available. These studies
provide insights into the basic structural framework of the MMP superf
amily and reveal characteristics which promote specificity between ind
ividual members. The analyses of the three dimensional structure of th
e MMPs in the context of their primary sequence and the design and sel
ectivity of low molecular weight inhibitors of the superfamily is the
subject of this review. (C) 1998 Elsevier Science Ltd. All rights rese
rved.